161 related articles for article (PubMed ID: 16481897)
1. Attitudes toward prenatal screening and testing for Fragile X.
Fanos JH; Spangner KA; Musci TJ
Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
[TBL] [Abstract][Full Text] [Related]
2. Fragile X screening: attitudes of genetic health professionals.
Acharya K; Ross LF
Am J Med Genet A; 2009 Feb; 149A(4):626-32. PubMed ID: 19291766
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
Meryash DL
Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
[TBL] [Abstract][Full Text] [Related]
4. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of population screening for fragile X syndrome.
Hill MK; Archibald AD; Cohen J; Metcalfe SA
Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
[TBL] [Abstract][Full Text] [Related]
6. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.
Lieberman S; Zuckerman S; Levy-Lahad E; Altarescu G
Am J Med Genet A; 2011 Sep; 155A(9):2154-60. PubMed ID: 21834046
[TBL] [Abstract][Full Text] [Related]
7. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
[TBL] [Abstract][Full Text] [Related]
8. A five-year experience with fragile X screening of high-risk gravid women.
Wenstrom KD; Descartes M; Franklin J; Cliver SP
Am J Obstet Gynecol; 1999 Oct; 181(4):789-92. PubMed ID: 10521730
[TBL] [Abstract][Full Text] [Related]
9. Challenges in prenatal screening and counselling for fragile X syndrome.
Mak AS; Leung KY
Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
[No Abstract] [Full Text] [Related]
10. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
[TBL] [Abstract][Full Text] [Related]
11. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
[TBL] [Abstract][Full Text] [Related]
12. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
[TBL] [Abstract][Full Text] [Related]
13. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
[TBL] [Abstract][Full Text] [Related]
14. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.
Boardman FK
J Genet Couns; 2021 Feb; 30(1):85-97. PubMed ID: 33184995
[TBL] [Abstract][Full Text] [Related]
16. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
Finucane B; Lincoln S; Bailey L; Martin CL
Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
[TBL] [Abstract][Full Text] [Related]
17. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study of Fragile X Syndrome Screening in Pregnant Women and Women Planning Pregnancy: Implementation, Acceptance, Awareness, and Geographic Factors.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
J Genet Couns; 2017 Jun; 26(3):501-510. PubMed ID: 27714485
[TBL] [Abstract][Full Text] [Related]
19. Screening for Fragile X Syndrome: parent attitudes and perspectives.
Skinner D; Sparkman KL; Bailey DB
Genet Med; 2003; 5(5):378-84. PubMed ID: 14501833
[TBL] [Abstract][Full Text] [Related]
20. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
